Mechanism of drug resistance and reversal with ligustra-zine and cyclosporin A in cisplatin-induced human epithelial ovarian cancer resistant cell line 3AO/CDDP

Chinese Journal of Cancer Research

Volumn 12, Issue 3, 2000, Pages 197-203

  Chen, Jian li ^a   Jiang, Sen ^a   Yang, Rui fang ^a   Liu, Fu sheng ^b   Sun, Xiao ming ^c  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Beijing Neurosurgery Institute   (China)

^c Central Hospital of Jinan   (China)

Author keywords

Chemotherapy; Cisplatin; Drug resistance; Multiple; Ovarian neoplasms

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GLUTATHIONE TRANSFERASE; LUNG RESISTANCE PROTEIN; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; PROTEIN DERIVATIVE; TENIPOSIDE; TETRAMETHYLPYRAZINE; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL KINETICS; CYTOTOXICITY; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTIDRUG RESISTANCE; OVARY CANCER; PROTEIN EXPRESSION;

EID: 0033792146     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02983467     Document Type: Article

References (18)

1. Chemotherapy in advanced ovarian cancer
2. Drug resistance in ovarian cancer: From the laboratory to the clinic
3. Multiple drug resistance in the human ovarian carcinoma cell line OAW42-A
4. Experimental study on the mechanism of cisplatin resistance and its reversion in human ovarian cancer
5. Biological characterization of multidrug resistant human colon carcinoma sublines induced by two methods
6. SDZPSC833, a non-immunosuppressive cyclosporine: Its potency in overcoming P-gp-mediated multidrug-resistance in murine leukemia
7. Study on the reversing effects of modulors on adrianiycin-resistant human bladder cancer cell line BIU-87/ADM
8. Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells
9. Advance in tumor resistance study
10. Resistance to alkylating agents and cisplatin: Insights from ovarian carcinoma model systems
11. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines
12. Glutatione, glutathione S-transferase α and π, and aldehyde dehydrogenase content m relationship to drug resistance in ovarian cancer
13. Glutathione S-transferase π expression and glutathione concentration in ovarian carcinoma before and after chemotherapy
14. Unlocking vaults: Organelles1 in search of a function
15. Drug resistance-associated marker 1rp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma
16. 1 gene expression by verapamil in multidrug-resistant leukemic cells
17. Cyclosporine A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells
18. The effects of cyclosporine A on the lysis of ovarian cancer cells by cisplatin or adriamycin